Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7OFF

Keap1 kelch domain bound to a small molecule inhibitor of the Keap1-Nrf2 protein-protein interaction

7OFF の概要
エントリーDOI10.2210/pdb7off/pdb
分子名称Kelch-like ECH-associated protein 1, SULFATE ION, DIMETHYL SULFOXIDE, ... (5 entities in total)
機能のキーワードkeap1, nrf2, oxidative stress, small molecule complex, maybridge, peptide binding protein
由来する生物種Mus musculus (Mouse)
タンパク質・核酸の鎖数1
化学式量合計34614.98
構造登録者
Narayanan, D.,Bach, A.,Gajhede, M. (登録日: 2021-05-04, 公開日: 2022-11-02, 最終更新日: 2024-01-31)
主引用文献Narayanan, D.,Tran, K.T.,Pallesen, J.S.,Solbak, S.M.O.,Qin, Y.,Mukminova, E.,Luchini, M.,Vasilyeva, K.O.,Gonzalez Chichon, D.,Goutsiou, G.,Poulsen, C.,Haapanen, N.,Popowicz, G.M.,Sattler, M.,Olagnier, D.,Gajhede, M.,Bach, A.
Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery.
J.Med.Chem., 65:14481-14526, 2022
Cited by
PubMed Abstract: Targeting the protein-protein interaction (PPI) between the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) and its repressor, Kelch-like ECH-associated protein 1 (Keap1), constitutes a promising strategy for treating diseases involving oxidative stress and inflammation. Here, a fragment-based drug discovery (FBDD) campaign resulted in novel, high-affinity ( = 280 nM), and cell-active noncovalent small-molecule Keap1-Nrf2 PPI inhibitors. We screened 2500 fragments using orthogonal assays─fluorescence polarization (FP), thermal shift assay (TSA), and surface plasmon resonance (SPR)─and validated the hits by saturation transfer difference (STD) NMR, leading to 28 high-priority hits. Thirteen co-structures showed fragments binding mainly in the P4 and P5 subpockets of Keap1's Kelch domain, and three fluorenone-based fragments featuring a novel binding mode were optimized by structure-based drug discovery. We thereby disclose several fragment hits, including their binding modes, and show how FBDD can be performed to find new small-molecule Keap1-Nrf2 PPI inhibitors.
PubMed: 36263945
DOI: 10.1021/acs.jmedchem.2c00830
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.37 Å)
構造検証レポート
Validation report summary of 7off
検証レポート(詳細版)ダウンロードをダウンロード

248335

件を2026-01-28に公開中

PDB statisticsPDBj update infoContact PDBjnumon